Anxiolytic profile of HG1, a 5-HT-moduline antagonist, in three mouse models of anxiety

European Neuropsychopharmacology

Volumn 14, Issue 6, 2004, Pages 449-456

  Clénet, Florence ^a   Hascoët, Martine ^a   Fillion, Gilles ^a   Galons, Hervé ^b   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Anxiety; Black and white test (B W); Elevated plus maze (EPM); Four plates test (FPT); Mouse; Serotonin (5 HT)

Indexed keywords

DIAZEPAM; LEUCYLSERYLALANYLLEUCINE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL TEST; GABAERGIC SYSTEM; HOT PLATE TEST; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; LIGHT; MALE; MICE; MOTOR ACTIVITY; NEUROPEPTIDES; OLIGOPEPTIDES; PIPERIDINES; SEROTONIN ANTAGONISTS;

EID: 10444278183     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2003.12.004     Document Type: Article

References (51)

1. Aron C., Simon P., Larousse C., Boissier J.M. Evaluation of a rapid technique detecting minor tranquillizers. Neuropharmacology. 10:1971;459-469
2. 1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis. Eur. J. Pharmacol. 358:1998;129-137
3. Blier P., Pineyro G., El Mansari M., Bergeron R., De Montigny C. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann. N.Y. Acad. Sci. 15:1998;204-216
4. Boissier J.R., Simon P. Action de la caffeine sur la motilité spontanée de la souri. Arch. Int. Pharmacodyn. 158:1965;212-221
5. 1B receptors in the rat brain. Eur. J. Pharmacol. 294:1995;531-540
6. Bonnin A., Grimaldi B., Fillion M.P., Fillion G. Acute stress induces a differential increase of 5-HT-moduline (LSAL), tissue content in various rat brain areas. Brain Res. 825:1999;152-160
7. 1B., receptor is localized predominantly on axon terminals. Neuroscience. 58:1994;167-182
8. Bourin M., Hascoët M. Drug mechanisms in anxiety. Curr. Opin. Investig. Drugs. 2:2001;259-265
9. Bourin M., Hascoët M. The mouse light/dark box test. Eur. J. Pharmacol. 463:2003;55-65
10. Bourin M., Hascoët M., David D., Nic Dhonnchadha B.A. D'Haenen H., Den Boer J.A., Willner P. Peptidergic Transmitter System and Anxiety Disorder in Biological Psychiatry. 2002;929-938 Wiley, Chichester
11. Briley M., Chopin P. Is anxiety associated with a hyper- or hypo-serotonergic state? Palomo T., Archer T. Depression, Anxiety and Drug Abuse Disorders. Studying Brain Disorders. vol. 1:1994;197-209 Editorial Complutense, Donoso Cortés, Madrid
12. Briley M., Chopin P., Moret C. Effects of serotonin lesions on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology. 101:1990;187-189
13. 1D binding sites in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:1993;569-582
14. 1A receptor antagonism on plus-maze behaviour in mice: II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav. 58:1997;593-603
15. 1A receptor ligands, LY293284, LY315712 and LY297996 on plus-maze anxiety in mice. Psychopharmacology. 139:1998;185-194
16. 1B/1D receptor ligands. Pharmacol. Ther. 62:1994;385-405
17. Clénet, F., Hascoët, M., Fillion, G., Galons, H., Bourin, M., submitted for publication. Influence of GABA-ergic and serotonergic systems in the anxiolytic mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze. Psychopharmacology.
18. 1B receptors. Proc. Natl. Acad. Sci. U. S. A. 94:1997;9899-9904
19. Crawley J.N. Neuropharmacologic specificity of a simple model for behavioural action of benzodiazepines. Pharmacol. Biochem. Behav. 15:1981;695-699
20. 1A compounds by GABA-benzodiazepine agents in rat. Pharmacol. Biochem. Behav. 60:1998;27-32
21. File S.E. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav. Brain Res. 125:2001;151-157
22. Fillion G., Fillion M.P. Modulation of affinity of postsynaptic serotonin receptors by antidepressant drugs. Nature. 292:1981;349-351
23. Fillion, G., Bourin, M., Galons, H., FR 2,815,031; 11-10-2000.
24. 1B knockout mice. Eur. J. Pharmacol. 421:2001;171-175
25. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther. 65:1995;319-395
26. Grimaldi B., Fillion M.P., Bonnin A., Rousselle J.C., Massot O., Fillion G. Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain. Neuropharmacology. 36:1997;1079-1087
27. Grimaldi B., Bonnin A., Fillion M.P., Prudhomme N., Fillion G. 5-HT-moduline: a novel endogenous peptide involved in the control of anxiety. Neuroscience. 93:1999;1223-1225
28. Hamon M., Gozlan H., El Mestikawy S., Emerit M.B., Cossery J.M., Lutz O. Biochemical properties of central serotonin receptors. Osborne N.N., Hamon M. Neuronal Serotonin. 1988;393-422 Wiley, Chichester
29. Hascoët M., Bourin M. A new approach to the light/dark procedure in mice. Pharmacol. Biochem. Behav. 60:1998;645-653
30. Hascoët M., Bourin M., Colombel M.C., Fiocco A., Baker G.B. Anxiolytic-like activity of various antidepressants after acute administration with the four plates paradigm in mice. Pharmacol. Biochem. Behav. 65:2000;339-345
31. Hen R. Structural and functional conservation of serotonin receptors throughout evolution. EXS. 63:1993;266-278
32. Kahawara H., Yoshida M., Yokoo H., Nishi M., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett. 162:1993;81-84
33. 1B receptors. J. Pharmacol. Exp. Ther. 292:2000;1111-1117
34. 1Dβ receptors in the rat, mouse and guinea pig with a specific antipeptide antiserum. J. Neurochem. 50:1995;752-762
35. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185
36. 1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the morris water maze. J. Neurosci. 19:1999;6157-6168
37. Marsden C.A., Stanford S.C. CNS drugs III: psychotherapeutics. Expert Opin. Investig. Drugs. 1:2000;104-109
38. 1B/1D receptors. Mol. Pharmacol. 50:1996;752-762
39. 1B receptors mediating inhibition of acetylcholine release. Eur. J. Pharmacol. 129:1986;313-319
40. 1B/1D receptors in psychiatric disorders and their potential as a target for therapy. Eur. J. Pharmacol. 404:2000;1-12
41. 2 ligands on three mouse models of anxiety. Behav. Brain Res. 140:2003;203-214
42. Pan Z.Z., Wessendorf M.W., Willliams J.T. Modulation by serotonin of the neurons in rat nucleus raphe magnus in vitro. Neuroscience. 54:1993;421-429
43. 1B receptor. J. Neurochem. 73:1999;2617-2620
44. 1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther. 237:1986;644-648
45. 1B receptor subtypes. J. Biol. Chem. 271:1996;726-735
46. 3H]dopamine from rat striatal synaptosomes. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;40-47
47. 1B receptors. Science. 265:1994;1875-1878
48. 1B receptors in the rat. Neurosci. Res. 27:1997;277-280
49. 1B agonists. Synapse. 1:1987;3-9
50. Zangen A., Overstreet D.H., Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J. Neurochem. 69:1997;2477-2483
51. 1B receptors. Neuropsychopharmacology. 21:1999;52S-60S